Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
165.91
-0.98 (-0.59%)
Sep 18, 2025, 3:30 PM IST
Nath Bio-Genes (India) Revenue
Nath Bio-Genes (India) had revenue of 2.84B INR in the quarter ending June 30, 2025, with 16.33% growth. This brings the company's revenue in the last twelve months to 4.05B, up 18.57% year-over-year. In the fiscal year ending March 31, 2025, Nath Bio-Genes (India) had annual revenue of 3.65B with 9.70% growth.
Revenue (ttm)
4.05B
Revenue Growth
+18.57%
P/S Ratio
0.78
Revenue / Employee
8.97M
Employees
451
Market Cap
3.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.65B | 322.73M | 9.70% |
Mar 31, 2024 | 3.33B | 314.02M | 10.42% |
Mar 31, 2023 | 3.01B | 230.01M | 8.26% |
Mar 31, 2022 | 2.78B | -291.99M | -9.49% |
Mar 31, 2021 | 3.08B | 276.70M | 9.89% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UltraTech Cement | 784.12B |
Asian Paints | 338.41B |
Grasim Industries | 1,539.86B |
Vedanta | 1,535.31B |
Pidilite Industries | 134.98B |
Solar Industries India | 80.10B |
Shree Cement | 194.40B |
Jindal Steel | 484.42B |